The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, ...

Drug companies are also reducing some prices on Jan. 1. Merck & Co MRK.N plans to cut the list price of its heavily discounted diabetes drugs Januvia and Janumet "to align the list price more ...